Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04140500
Title Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

melanoma

esophagus squamous cell carcinoma

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

RO7247669

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST